*Department of Hematopathology

†Department of Translational Molecular Pathology

§Department of Breast Imaging

∥Department of Pathology

¶Department of Breast Surgical Oncology

#Department of Plastic Surgery

**Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston

‡Department of Pathology, University of Texas Medical Branch, Galveston, TX

††Department of Pathology, The University of Vermont Larner College of Medicine, Burlington, VT

‡‡Department of Pathology, Kings Daughters Medical Center, Ashland, KY

§§Universidad Peruana Cayetano Heredia, Lima, Peru and Roche Diagnostics, Lima, Peru

∥∥Houston Methodist, Breast Surgical Oncology, Houston, TX

¶¶Revalla Plastic Surgery and Medical Esthetics, Denver, CO

##Caris Life Sciences, Phoenix, AZ

***Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA

†††Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN

The study was supported with own funds of the Department of Hematopathology.

Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Correspondence: Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston 77030, TX (e-mail: [email protected]).